Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND)
Clinical trial NCT06299553 · RECRUITING
Trial details
- NCT number
- NCT06299553
- Sponsor
- Incyte Biosciences Italy S.r.l
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2023-12-04
- Primary completion
- 2025-06-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.